XENIOS Platform

XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering  lung and heart therapies on one single platform.

THE PERFECT MATCH FOR YOUR NEEDS

  • the unique platform for three applications combining ICU (novalung: iLA activve system platform), cath lab (i-cor: i-cor system) and OR (medos: deltastream system)
  • adapt the system to your needs
  • increased safety through integrated emergency functions